On April 21, Junshi Bio-U (688180) rose 5.51% and closed at 86.1 yuan. Please see the table below for the top ten funds of Chongcang Junshi Bio-U: Junshi Bio's 2021 annual report shows that the company's main operating income was 4.025 billion yuan, a year-on-year increase of 152

4 On April 21, Junshi Biotechnology -U (688180) rose 5.51%, closing at 86.1 yuan. Please see the table below for the top ten funds of

Junshi Biotech-U:

Junshi Biotechnology's 2021 annual report shows that the company's main operating income was 4.025 billion yuan, a year-on-year increase of 152.36%; the net profit attributable to the parent company was -720.9097 million yuan, a year-on-year increase of 56.8% %; excluding non-net profit -884.0489 million yuan, a year-on-year increase of 48.27%; in the fourth quarter of 2021, the company's single-quarter main operating income was 1.306 billion yuan, a year-on-year increase of 123.72%; single-quarter net profit attributable to the parent company -328.7832 million yuan, year-on-year Increased 40.54%; non-net profit in a single quarter was -349.7857 million yuan, a year-on-year increase of 40.82%; debt ratio was 24.64%, investment income was -47.187 million yuan, financial expenses were 31.3656 million yuan, and gross profit margin was 69.08%. A total of 10 institutions have rated the stock in the past 90 days, buy rating 10; the average target price of institutions in the past 90 days is 103.59.

According to the 2022Q1 quarterly report fund heavy holdings data, there are 10 funds holding heavy positions in this stock. Among them, the fund with the largest number of holdings is China Shanghai Stock Exchange Science and Technology Innovation Board 50 component ETF. The current size of ChinaAMC SSE Science and Technology Innovation Board 50-component ETF is 20.689 billion yuan, with the latest net value of 1.1822 (March 22), down 1.57% from the previous day and down 7.57% in the past year. The current fund manager of this fund is Zhang Hongtao. The public funds Zhang Hongtao serves include: ChinaAMC CSI1 CSI 300ETF Link A, the management period is from July 10, 2009 to the present, with a return rate of 42.63% during the period; ChinaAMC CSI 300ETF, the management period is from December 25, 2012 to the present, during the period The return rate is 102.25%; ChinaAMC Online Shopping Select Mix A, the management period is from November 2, 2016 to the present, and the return rate during the period is 19.5%; China AMC SSE 50 ETF, the management period is from November 18, 2016 to the present, and the return rate during the period is 33.56%. The public funds that have been honored include: ChinaAMC CSI 500 ETF Link A, the management period is from October 20, 2016 to the present, with a return rate of 1.18% during the period; ChinaAMC CSI 500ETF, the management period is from October 20, 2016 to the present, during the period The return rate is 1.32%; ChinaAMC SSE 50AH Preferred Index A, the management time is from October 27, 2016 to the present, and the return rate during the period is 37.6%; ChinaAMC CSI Central Enterprise ETF, the management time is from October 19, 2018 to the present, the return rate during the period The rate is 21.37%.

The top ten holdings of the China Shanghai Securities Science and Technology Innovation Board 50-component ETF are as follows:

The above content is compiled by Securities Star based on public information. If you have any questions, please contact us.